AI health companion, Ada Health intensifies collaboration with German Accelerator Life Sciences (GALS) as it expands to the US. Following the successful closing of a $47M funding round, Ada will accelerate operational and partnership developments in a rapidly growing US market. The London and Berlin-based health technology company has developed a health companion and telemedicine app as well as a decision support tool for medical professionals, which launched in late 2016.

The Personal Connected Health Alliance (PCHAlliance) today released the latest version of the Continua Design Guidelines (CDGs) to enable the secure, private, reliable and accurate sharing of patient generated health data (PGHD) with healthcare providers, built-on HL7 FHIR (Fast Healthcare Interoperability Resources) specifications. The Design Guidelines now support the integration of personal health data from

Rockstart Digital Health Accelerator provides an unparalleled access to the healthcare ecosystem, capital, coaching and investors for entrepreneurs who are looking to change the way things are done in healthcare. It will help you better understand product design, market fit and business models by enabling you to directly work with patients, professionals and other stakeholders.

Vertical is not your typical startup accelerator, it does not cover startups pitch training, vision/mission or product-market-fit. VERTICAL expects entrepreneurs to have the fundamentals of their ventures in place. Vertical team combines the tenacity of start-up fervour with the experienced corporate world, the accelerator collaborates to create industry-first developments and pave the way forward.

Boehringer Ingelheim has announced the launch of opnME.com, a new platform offering free and open access to selected pre-clinical molecules for non-clinical investigation to scientists worldwide. Through opnME.com, molecules for some of the most relevant targets in biomedical research are shared, thereby creating possibilities for further independent and collaborative discovery as well as the identification of novel treatment approaches for patients.

The Bundesnetzagentur prohibits the sale of children's watches that have an "eavesdropping" function and has already taken action against several offers on the internet. "Parents can use these children's watches to listen in to the child's surroundings without detection via an app. The watches are regarded as unauthorised transmitting equipment," said Jochen Homann, Bundesnetzagentur President. "Our investigations found, for example, that parents were using them to eavesdrop on teachers in lessons."

Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. Under the agreement, Roche is acquiring all shares of the company. The acquisition, which is subject to customary closing conditions, is expected to close on November 21, 2017.